Sonnet BioTherapeutics Publishes Key Data On SON-1010 IL-12 Fusion Protein In Frontiers In Immunology, Highlighting Mechanism Of Action And Enhanced Tumor Targeting With Patents Secured Through 2039
Sonnet生物治療公司在《免疫學前沿》雜誌上發表關於SON-1010 IL-12融合蛋白的重要數據,突出作用機制以及通過2039年獲得的專利保障